HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion
- PMID: 15380356
- DOI: 10.1016/j.virol.2004.07.015
HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion
Abstract
We recently described a sensitive and specific assay that detects the fusion of HIV-1 virions to a broad range of target cells, including primary CD4 cells. This assay involves the use of virions containing beta-lactamase-Vpr (BlaM-Vpr) and the loading of target cells with CCF2, a fluorogenic substrate of beta-lactamase. Since Vpr strongly associates with the viral core, uncoating of the viral particle might be required for effective cleavage of CCF2 by BlaM-Vpr. Here, we show that BlaM-Vpr within mature viral cores effectively cleaves CCF2, indicating that this assay measures virion fusion independently of uncoating. We also show that wildtype and Nef-deficient HIV-1 virions fuse with equivalent efficiency to HeLa-CD4 cells, SupT1 T cells, and primary CD4 T cells. Since Nef enhances cytoplasmic delivery of viral cores and increases viral infectivity, these findings indicate that Nef enhances an early post-fusion event in the multistep process of viral entry. Possible sites of Nef action include enlargement of the fusion pore, enhanced uncoating of viral particles, and more efficient passage of viral cores through the dense cortical actin network located immediately beneath the plasma membrane.
Copyright 2004 Elsevier Inc.
Similar articles
-
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.Nat Biotechnol. 2002 Nov;20(11):1151-4. doi: 10.1038/nbt745. Epub 2002 Sep 30. Nat Biotechnol. 2002. PMID: 12355096
-
Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.J Hum Virol. 2000 Jan-Feb;3(1):6-15. J Hum Virol. 2000. PMID: 10774802
-
Fluorescence resonance energy transfer-based HIV-1 virion fusion assay.Methods Mol Biol. 2004;263:333-44. doi: 10.1385/1-59259-773-4:333. Methods Mol Biol. 2004. PMID: 14976375
-
Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?Biochem Biophys Res Commun. 2000 Jan 27;267(3):677-85. doi: 10.1006/bbrc.1999.1708. Biochem Biophys Res Commun. 2000. PMID: 10673351 Review.
-
[Functional roles of HIV-1 accessory genes for its pathogenicity].Tanpakushitsu Kakusan Koso. 2007 Aug;52(10 Suppl):1261-7. Tanpakushitsu Kakusan Koso. 2007. PMID: 17824250 Review. Japanese. No abstract available.
Cited by
-
The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.Curr HIV Res. 2011 Oct;9(7):474-89. doi: 10.2174/157016211798842099. Curr HIV Res. 2011. PMID: 22103831 Free PMC article. Review.
-
HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer.Retrovirology. 2013 Jul 30;10:80. doi: 10.1186/1742-4690-10-80. Retrovirology. 2013. PMID: 23899341 Free PMC article.
-
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.Proc Natl Acad Sci U S A. 2010 May 18;107(20):9364-9. doi: 10.1073/pnas.1001554107. Epub 2010 May 3. Proc Natl Acad Sci U S A. 2010. PMID: 20439730 Free PMC article.
-
Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay.Virology. 2007 Nov 10;368(1):1-6. doi: 10.1016/j.virol.2007.06.022. Epub 2007 Jul 19. Virology. 2007. PMID: 17640696 Free PMC article.
-
IL-27 posttranslationally regulates Y-box binding protein-1 to inhibit HIV-1 replication in human CD4+ T cells.AIDS. 2019 Oct 1;33(12):1819-1830. doi: 10.1097/QAD.0000000000002288. AIDS. 2019. PMID: 31274540 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials